Let’s celebrate the rising stars of biotech and pharma! BioSpace's 40 Under 40 honors emerging leaders making a real impact. Nominate a life sciences leader today:. #biotech #lifescineces #biospace40under40 #biospace

After “issues” with a batch of its investigational antibody briquilimab “confounded” the readout of Jasper Therapeutics’ Phase Ib/IIa BEACON study in chronic spontaneous urticaria (CSU), the California-based biotech is laying off approximately half of its staff. Get the details.

The deal gives @AstraZeneca's rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR Pharmaceuticals for use in up to five of Alexion’s gene therapies. #genetherapy #biospace .

In the second biggest acquisition of the year, @Merck gains the commercial COPD drug Ohtuvayre, which could help offset the loss of revenue when Keytruda’s patent expires later this decade. #acquisition #COPD #biospace.

The high court’s order blocks a May decision by a California court that temporarily blocked the efforts of Health Secretary Robert F. Kennedy Jr. to drastically reduce the size of his agency’s workforce. #HHS #supremecourt #biospace.

The @US_FDA will allow a new dosing schedule for @EliLillyandCo's Alzheimer’s drug Kisunla that could lessen a known side effect of the monoclonal antibody drug class that has led to several deaths. #FDA #alzheimers #biospace.

Actithera’s radiopharma assets irreversibly bind to their targets, allowing for longer retention of the drug inside tumors. #radiopharma #biospace .

Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these six biotechs are playing in the largely underappreciated longevity space, developing therapies that may improve the quality of aging. #startups #biotech.

H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health Secretary Robert F. Kennedy Jr. and a plea from patients with ALS for access to.

Leerink Partners called the announcement a ‘positive’ given the delayed timeframe and the uncertainty that the administration will implement tariffs at all. #tariffs #pharma #biospace.

Analysts said the deal with @novonordisk was likely giving Hims “‘credibility’ or increased consumer traffic,” adding that the “litigation risk is back on the table” now that the Danish pharma has stepped away. #weightloss #pharma #biospace.

The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan. #biotech #biospace .

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the approval of its cell therapy NurOwn, whose BLA was withdrawn in 2023. A Phase IIIb trial was scheduled to begin last month. #ALS #FDA #biospace.

The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since the January decision to halt its lead candidate for a certain type of aggressive large B cell lymphoma. #biotech #merger #biospace.

The Australian multinational biotech @CSL is consolidating its research and development team. Learn more in our layoff tracker. #layoffs #biopharma #biospace.

President Donald Trump’s One Big Beautiful Bill, signed into law last week, reintroduces broader exemptions for orphan drugs from the IRA’s drug price negotiation program—a move welcomed by the biopharma industry. The new tax law also cuts Medicaid funding, posing a minimal risk.

Join us next week for a live webinar - Pharma Industry in Crisis: How to Preserve Quality While Balancing Budget and Time in Today’s Financial Climate. In this interactive webinar industry experts will explore actionable strategies for maintaining quality under financial

After issues with a batch of Jasper Therapeutics’ investigational antibody led to “lower” therapeutic effects in several patients, analysts at BMO Capital Markets said they “believe investors won’t feel comfortable coming back to the story.”. #immunology #biospace.

Societies, including the American Academy of Pediatrics, allege that Kennedy’s directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and healthy children puts these vulnerable groups at risk of serious illness. #legal #vaccine #biospace.

A readout from the company’s SUMMIT trial put its small molecule bezuclastinib on a collision course with rival Blueprint’s Ayvakit, which Leerink analysts said does not sufficiently treat all patients. #biospace .